The American Lung Association in Kentucky has awarded the "Lung Cancer Discovery Award" grant to Dr. Nadiia Lypova from the University of Louisville Research Foundation, Inc. Dr. Lypova's research will focus on drug-resistant tumor cells in non-small cell lung cancer. Her work aims to uncover vulnerabilities in these resistant cells and develop new treatment strategies.
Whitten Montgomery, Executive Director at the Lung Association, stated, “In 2024, the American Lung Association is celebrating 120 years of funding lifesaving research. Lung Association researchers have achieved major milestones, including helping end the devastation of tuberculosis in this country, saving millions of lives of premature babies with respiratory distress syndrome (RDS), supporting research on COVID-19 and much more." He emphasized the importance of ongoing research given that "238,000 people [are] predicted to be diagnosed with lung cancer this upcoming year."
The American Lung Association Research Institute has announced a $22 million investment in research over the past year. This makes it one of the largest programs dedicated to lung health in the United States. The institute funded 144 research grants covering various aspects of lung disease through different awards.
These awards include categories such as the American Lung Association/AAAAI Allergic Respiratory Diseases Award and the Emerging Respiratory Diseases Award. Each project is selected through a rigorous scientific peer review process.
The association is currently accepting applications for its 2025-2026 research awards cycle. More information can be found at Lung.org/awards and about their research team at Lung.org/research-team.
